Trimetazidine Prevents Renal Fibrosis Induced by Cyclosporine A in Wister Rats
Journal Title: Journal of Pharmaceutical Research International - Year 2015, Vol 7, Issue 2
Abstract
Cyclosporine A (CyA), an immunosuppressant administered to transplant patients, causes adverse effects such as nephrotoxicity and hepatotoxicity. In kidney slices of rats treated with 25 mg/kg/day of CyA we observed interstitial fibrosis. Ultrastructure revealed edematized mitochondria with loss of internal structure. In previous work with Trimetazidina (TMZ), cytoprotective drug used in cardiac patients, we found that TMZ prevents CyA toxicity. The pretreatment in wister rats with 20 mg/kg/day of TMZ during 20 days and them simultaneously TMZ with cyclosporine A for 120 days, counteracts the interstitial fibrosis. The aim of this work is to elucidate the effect of TMZ on interstitial fibrosis and interpret its mechanism. Four groups of eight male Wister rats were prepared. A, control; B, 25 mg/Kg/day CyA; C, 20 mg/Kg/day TMZ +25 mg/Kg/day CyA and D, 20 mg/Kg/day TMZ for 20 days and then TMZ 20 mg/Kg/day + CyA 25 mg/Kg/day. The experiment lasted 140 days. Slices of rats treated with CyA revealed fibrosis, which was quantified using Image Pro-Plus software (NIH). Immunohistochemical techniques evidenced Collagen type I, Transforming Growth Factor β1 (TGF-β1) and Monocyte Chemoattractant Protein-1 (MCP-1). However, pretreatment with TMZ for 20 days and then with CyA + TMZ prevented fibrosis and immunohistochemistry was negative for the markers studied. We concluded that TMZ protects the cells against the changes produced by the CyA-induced oxygen deficit. TMZ could offset ATP synthesis caused by the chronic administration of CyA. TMZ optimizes the energetic metabolism of the ischemic cell through a metabolic exchange (“switch”) between the fatty acid and glucose oxidation. In theory TMZ would reduce strongly the fatty acid oxidation towards glucose, without affecting the mitochondrial respiratory chain efficiency. Furthermore, TMZ increases the production of phospholipids in the mitochondrial membranes, which confers stability to these structures. In previous work check the effect of CyA on the complex I and II of the mitochondrial respiratory chain located in mitochondrial membranes which are the target of the toxic action of CyA.
Authors and Affiliations
De la Cruz Rodríguez Lilia Cristina, Rey María del Rosario, Ana Verónica Oldano
Keywords
Related Articles
- EP ID EP344310
- DOI 10.9734/BJPR/2015/17390
- Views 64
- Downloads 0
Diclofenac-induced Gastric Ulceration in Rats: Protective Roles of Pantoprazole and Misoprostol
Gastrointestinal damage caused by diclofenac remains a significant clinical problem. Pantoprazole provides potent and long-lasting inhibition of gastric acid secretion and has proven efficacy in healing diclofenac-associ...
Antimicrobial Activity of Bridelia micrantha and Grewia plagiophylla Leaf Extracts
Escalation in occurrences of resistant microorganisms especially to synthetic drugs, has obliged the need to search for new bioactive compounds having natural origin. Bridelia micrantha and Grewia plagiophylla are medici...
Antibacterial Activity of Pennisetum glaucum Crude Extracts and Pre-purified Fractions against Selected Pathogenic Microorganisms
Background: Penisetum glaucum is one of the earliest indigenous food crops in East Africa. Pearl millet contains numerous phytocompounds. Isolation and characterization of secondary metabolites from pearl millet and eval...
In vitro and in vivo Antitrypanosomal Effects of Methanol and Aqueous Extracts of Picralima nitida
The methanol and aqueous extracts of the leaves, fruits, seeds, stem bark and roots of Picralima nitida were studied in vitro and in vivo for activity against Trypanosoma brucei brucei in Swiss albino mice. Phytochemical...
Synergistic Activity of the Antibiotic Meropenem in Combination with Edible Mushroom Extracts against Multidrug Resistant Bacteria
Aims: The objective of this study was to evaluate the antibacterial potency of meropenem in synergism with five edible mushroom extracts against multidrug resistant clinical isolates. Methodology: Minimum Inhibitory Con...